Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension.
about
From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertensionProtective Role of the ACE2/Ang-(1-9) Axis in Cardiovascular Remodeling.ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesionDarapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in AtherosclerosisRole of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart FailureThe Rho/Rho-associated protein kinase inhibitor fasudil in the protection of endothelial cells against advanced glycation end products through the nuclear factor κB pathway.Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin-angiotensin system.Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system.ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.Diuretics prevent Rho-kinase activation and expression of profibrotic/oxidative genes in the hypertensive aortic wall.Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421.Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes.Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor.
P2860
Q33795353-D024EF13-0100-40B3-9A77-7EFE63F9E0B1Q35726197-80AEBC29-9F5F-4677-8935-C59E1DCFD386Q36288958-68C79209-8AA3-427B-8018-A9F6540A2880Q36541529-3B23B19D-86A6-4B79-89A2-3B984163AEE3Q37081415-033653ED-3B58-4DD2-B725-FB1D6CBFEF49Q37207216-5A837740-2B7B-4CCA-B8F3-45A62694171DQ37450106-5342E6A4-C1A0-4DE9-A68B-1DD4181F72D1Q38069197-7FFD0BF7-39CE-4168-88F6-288340745AD7Q38193206-7C4EA140-95E8-4268-AF15-20C36B13B8DFQ38230104-0672D41D-3C52-4AAB-9B77-952CDFCB69A0Q38567063-C822F96F-DFFF-4ABE-9644-D600CFC9271FQ39429512-E113C754-41DC-4248-80AB-EAD1BA3C4BB7Q48553675-7B1D8581-D780-4F06-A39E-75D4DB7CCCEEQ51108938-AA2F16EE-BCCE-46AE-977F-71B917E4736FQ53447070-FA37BD26-300B-4695-A970-6B54E18402EFQ55360608-3E2EA4E6-EB06-499E-AD2C-D0DFF3CD078B
P2860
Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-(1-9) axis in experimental hypertension.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-
@nl
Rho kinase inhibition activate ...... in experimental hypertension.
@ast
Rho kinase inhibition activate ...... in experimental hypertension.
@en
type
label
Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-
@nl
Rho kinase inhibition activate ...... in experimental hypertension.
@ast
Rho kinase inhibition activate ...... in experimental hypertension.
@en
prefLabel
Rho kinase inhibition activates the homologous angiotensin-converting enzyme-angiotensin-
@nl
Rho kinase inhibition activate ...... in experimental hypertension.
@ast
Rho kinase inhibition activate ...... in experimental hypertension.
@en
P2093
P1476
Rho kinase inhibition activate ...... in experimental hypertension.
@en
P2093
Jorge E Jalil
Leticia González
María P Ocaranza
Melissa Pinto
Paulina Rivera
Ulises Novoa
P304
P356
10.1097/HJH.0B013E3283440665
P577
2011-04-01T00:00:00Z